Alexza Pharma (ALXA) Volatility Up; Shares Rip Higher on ADASUVE NDA Resubmission
Tweet Send to a FriendGet Alerts ALXA Hot Sheet
Up)
Trade ALXA Now!
Alexza Pharmaceuticals (Nasdaq: ALXA) volatility is up as share rip higher Friday morning following resubmission of its ADASUVE New Drug Application to the U.S. FDA in response to a Complete Response Letter (CRL) received in May 2012.
Volatility is up 5.5 percent from yesterday's close. Shares are up 42 percent on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Volatility is up 5.5 percent from yesterday's close. Shares are up 42 percent on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Cleantech Solutions (CLNT) Becomes Certified Supplier to Sinopec and CPNC
- Canadian Solar (CSIQ) Continues Higher Following Arbitration Win Over LDK (LDK)
Create E-mail Alert Related Categories
Insiders' Blog, Momentum Movers, Options
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
